SPRAVATO™

A First of Its Kind Depression Treatment

What Is SPRAVATO™?

SPRAVATO™, or Esketamine, is an innovative FDA-approved treatment that has relieved thousands of individuals suffering from treatment-resistant depression. Administered as a nasal spray under the supervision of a  certified healthcare provider, SPRAVATO™ is unique in that it may be able to alleviate symptoms of depression within hours rather than the weeks or months a typical antidepressant may take. While a standard antidepressant, such as the SSRIs Fluoxetine (Prozac) or Sertraline (Zoloft), targets specific neurotransmitters in the brain like serotonin, SPRAVATO™ targets the NMDA receptor within nerve cells and helps reset these connections between nerve cells. SPRAVATO™ went through both short-term and long-term trials before the FDA approved it for use with treatment-resistant depression.

Spravato nasal spray close up

Treatment-Resistant Depression

Depression is not as simple as just “sadness.” Sadness is a feeling that comes and goes with everyday life. Almost 300 million people suffer from depression worldwide, and despite a variety of depression treatments available, many continue to suffer without relief from these medications.

Fortunately, SPRAVATO™ – the breakthrough FDA-approved esketamine nasal spray – is showing excellent results in relieving those symptoms of depression. As a SPRAVATO™ REMS-certified treatment provider, our treatment team can alleviate even the most severe forms of treatment-resistant depression.

How Is SPRAVATO™ Different?

Rising depression rates worldwide make one thing clear: the current antidepressants so commonly prescribed are not bringing adequate relief to all those suffering. These oral antidepressants typically aim to treat depression by increasing certain neurotransmitters in the brain to affect mood. SPRAVATO™ works differently – it targets the NMDA receptor antagonist and may be able to reset and restore neuronal connections. Through this, SPRAVATO™ can treat the disorder, not just the symptoms.

Major Depressive Disorder with Suicidal Ideation Dosage

Treatment Resistant Depression Dosage

Do I Qualify for SPRAVATO™ Treatment?

If you meet the criteria above, we invite you to contact us for a free consultation to find out if SPRAVATO™ treatment is right for you.

Robin's Story

“SPRAVATO™ helped me get beyond the depression symptoms that held me back for so long. Today, I’m leading a class in mental health, building a greenhouse in my backyard and spending time at the beach with my dog, Oshi. I’ve been on SPRAVATO™ and I go every other week for my treatment. Having my depression symptoms improve after a lifetime of struggle has been amazing…”

-Robin P,  Orlando, FL

Stop Suffering. Find Relief. Hope Is Here.

Ketamine Can Help

Rapid Relief for Many Mood and Chronic Conditions

Ketamine treatments have proven to be highly effective in treating mood disorders, eliminating suicidal ideations, and alleviating other chronic conditions.
Depression
Depression
Read More
Ketamine has been shown to relieve the symptoms of depression within hours, instead of weeks.
Anxiety
Anxiety
Read More
Ketamine has been shown to relieve the symptoms of anxiety and panic in those suffering from these conditions.
PTSD
PTSD
Read More
Those suffering from PTSD after one or more traumatic events may find relief with ketamine therapy.
Migraines
Migraines
Read More
Patients have been finding relief from the pain and symptoms of migraines with ketamine therapy.
ALS
ALS
Read More
Ketamine has been proven to be highly effective in treating chronic pain conditions such as ALS.
OCD
OCD
Read More
Ketamine has been proven to be highly effective in treating Obsessive Compulsive Disorder.
Previous
Next